The effect of menopausal hormone therapy on thyroid cancer survivors from the National Health Insurance Database in South Korea cohort
The risk of death in postmenopausal TC survivors who used MHT for > 5 years did not differ from that of their counterparts who did not use MHT. However, postmenopausal TC survivors who used MHT for < 5 years, particularly those who used MHT for < 6 months, had a higher risk of death than their counterparts who did not use MHT.
Authors
- Sang‐Hee Yoon (ORCID: https://orcid.org/0000-0002-5723-5105)
- Myounghwan Kim (ORCID: https://orcid.org/0000-0002-8914-4267)
- Sam-Youl Yoon
- Gwan Hee Han (ORCID: https://orcid.org/0000-0001-5263-4855)
- Jin‐Sung Yuk (ORCID: https://orcid.org/0000-0002-5478-634X)
- Geumhee Gwak (ORCID: https://orcid.org/0000-0002-7910-1052)
- Yujin Lee (ORCID: https://orcid.org/0000-0001-5660-5701)
- Hyun‐Jin Cho (ORCID: https://orcid.org/0000-0002-6518-351X)
- Jungbin Kim (ORCID: https://orcid.org/0000-0001-5839-619X)
- Ji Hyun Noh (ORCID: https://orcid.org/0009-0002-3713-7986)
- Yeonjin Shin (ORCID: https://orcid.org/0009-0006-7901-2419)
- Jin Li Lee (ORCID: https://orcid.org/0009-0006-6218-7175)
- Keunho Yang
- Ki Whan Kim
- Byung Noe Bae
Institutions
- Inje University Sanggye Paik Hospital (KR)
Publication Details
- Journal
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1016/j.ejogrb.2025.113983
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00